A Virus Designed in the Lab Could Help Defeat Antibiotic Resistance Scientists can now design bacteria-killing viruses from DNA, opening a faster path to fighting superbugs.

A Virus Designed in the Lab Could Help Defeat Antibiotic Resistance #Science #HealthandMedicine #InfectiousDiseases #AntibioticResistance #ViralTherapy

scitechdaily.com/a-virus-designed-in-the-...

Century-Old Viral Therapy Could Help Us Out of an Impending Superbug Crisis Quite the comeback.

Century-Old Viral Therapy Could Help Us Out of an Impending Superbug Crisis #Science #HealthandMedicine #InfectiousDiseases #Superbugs #ViralTherapy

Emerging Trends in Oncolytic Viral Therapy: Innovations from Preclinical to Translational Research Explore innovative oncolytic virus strategies at AACR 2025. Learn about tumor-selective therapy and immune modulation compared to AAV-based gene therapy.

Emerging Trends in Oncolytic Viral Therapy: Innovations from Preclinical to Translational Research
-Highlights from the 2025 AACR Meeting
Link to the news article: www.marinbio.com/emerging-tre...

#onclyticvirus #oncolyticvirotherapy #viraltherapy. #cancertherapy #immunotherapy #cancer

📌 OncoTerm - Word of the Day! 👋

📌 OncoTerm - Günün Kelimesi! 👋

Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.

#Onco404 #Cancer #Kanser #CancerAwareness #OncolyticVirus #ViralTherapy #Immunotherapy #MedSky #OncSky #AcademicSky #Vocabulary

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive canc...

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy 🔬✨🌿 www.news-medical.net/news/2024110... #Curcumin #Cancer #EpsteinBarrVirus #HSP90 #LyticCycle #ViralTherapy #Oncology #Virus